4
Changes in Ownership
10x Genomics, Inc. Filed Acc 0001209191-21-049650
Chief Financial Officer sold 10,000 shares at an average $180.38 ($1,803,821)
- Chief Financial Officer acquired 10,000 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
McAnear Justin J. · Chief Financial Officer
Table I: Non-derivative
8 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2021-08-02 | Exercise or conversion : show line 1 in the form | +10,000 | $5.04 | $50,400 | 49,370 | D |
| 2021-08-02 | Sale : show line 2 in the form | −1,698 | $178.35 | $302,840 | 47,672 | D |
| 2021-08-02 | Sale : show line 3 in the form | −2,202 | $179.28 | $394,780 | 45,470 | D |
| 2021-08-02 | Sale : show line 4 in the form | −2,298 | $180.29 | $414,304 | 43,172 | D |
| 2021-08-02 | Sale : show line 5 in the form | −2,302 | $181.31 | $417,376 | 40,870 | D |
| 2021-08-02 | Sale : show line 6 in the form | −700 | $182.16 | $127,514 | 40,170 | D |
| 2021-08-02 | Sale : show line 7 in the form | −500 | $183.30 | $91,650 | 39,670 | D |
| 2021-08-02 | Sale : show line 8 in the form | −300 | $184.52 | $55,357 | 39,370 | D |
| Open-market sales · 10,000 sh · avg $180.38 · $1,803,821 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| 2021-08-02 | Exercise or conversion : show line 9 in the form Stock Option (right to buy) | −10,000 | $5.04 | 2028-11-02 | 10,000 | 400,159 | D |
Loading xslF345X03/doc4.xml…